Amelioration of Inflammation and Cytotoxicity by Dipyridamole in Brain Endothelial Cells
- 23 July 2010
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 30 (3), 290-296
- https://doi.org/10.1159/000319072
Abstract
Background: Increasing evidence suggests that beyond its antiplatelet properties, dipyridamole may have pleiotropic effects on other cells within the neurovascular elements of the brain. In this experimental cellular study, we asked whether dipyridamole can ameliorate brain endothelial injury after exposure to inflammatory and metabolic insults. Methods: Human brain endothelial cells were grown in culture, and exposed to TNFα (continuously for 20 h) or subjected to oxygen-glucose deprivation (OGD; 6 h of insult followed by 18 h recovery). Expression of ICAM-1, VCAM-1 and PECAM-1 were measured by immunoblotting. Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in the conditioned media were quantified via zymography. MTT mitochondrial activity was measured to assess endothelial cell viability. Results: Exposure of human brain endothelial cells to TNFα (12.5–50 ng/ml) induced a clear increase in protein levels of ICAM-1, VCAM-1 and MMP-9. TNFα did not alter PECAM-1. Dipyridamole (1–5 µM) significantly attenuated ICAM-1 and MMP-9 levels after this inflammatory insult. No significant effects of dipyridamole were noted for VCAM-1. Six-hour OGD induced moderate endothelial cell death accompanied by a release of MMP-9. Dipyridamole significantly decreased MMP-9 levels and cell death after this metabolic insult. Conclusions: These results suggest that dipyridamole may ameliorate brain endothelial injury after inflammation and/or metabolic insults. How these putative cellular mechanisms may relate to clinical outcomes and conditions in stroke patients remains to be elucidated.Keywords
This publication has 37 references indexed in Scilit:
- Antithrombotic Agents in the Prevention of Ischemic StrokeCerebrovascular Diseases, 2009
- CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layerJournal of Neuroimmunology, 2004
- Induction of Caspase-Mediated Cell Death by Matrix Metalloproteinases in Cerebral Endothelial Cells after Hypoxia—ReoxygenationJournal of Cerebral Blood Flow & Metabolism, 2004
- Biochemical Changes and Inflammatory Response as Markers for Brain Ischaemia: Molecular Markers of Diagnostic Utility and Prognosis in Human Clinical PracticeCerebrovascular Diseases, 2003
- Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activatorNature Medicine, 2003
- Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-$alpha;Molecular Brain Research, 2003
- Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral IschemiaJournal of Neuroscience, 2001
- Anti‐ICAM‐1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the ratNeurology, 1994
- A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivityBritish Journal of Cancer, 1987
- Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.